MSB 3.83% $1.26 mesoblast limited

Cell Therapy News/Articles, page-3820

  1. 509 Posts.
    lightbulb Created with Sketch. 380
    Recent Articles by Abhijit Duggal, MD. Principal Investor for Ohio

    Respiratory failure in patients infectedwith SARS-CoV-2Posted April 18, 2020
    https://www.ccjm.org/content/ccjom/early/2020/05/18/ccjm.87a.ccc025.full.pdf

    Spontaneous echo contrast in venous ultrasound of severe COVID-19 patients Posted May 27, 2020
    https://link.springer.com/article/10.1007/s00134-020-06094-3?code=c6c6c42f-969f-4614-ac97-bd133d663334

    Acute kidney injury in acute respiratory distress syndrome: why ventilator settings matterPosted May 2020
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290557/

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $21.32M 17.21M

Buyers (Bids)

No. Vol. Price($)
4 5460 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 978 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.